What is Fluence?
Fluence operates as an expertise-driven educational platform, bridging the critical gap between emerging psychedelic research and clinical application. By providing rigorous training for psychiatrists, psychotherapists, and social workers, the company ensures that healthcare providers possess the evidence-based skills necessary for safe and effective patient care. As the demand for alternative mental health treatments grows, Fluence serves as a vital conduit for professional development, offering both interactive online modules and in-person workshops that define the standard for psychedelic-assisted therapy education.
How much funding has Fluence raised?
Fluence has raised a total of $3M across 1 funding round:
Angel/Seed
$3M
Angel/Seed (2022): $3M with participation from Baroda Ventures, The JLS Fund, Foundation Capital, Learn Capital, Iter Investments, Palo Santo, Neo Kuma Ventures, and Evolve Ventures
Key Investors in Fluence
The JLS Fund
A venture capital fund established in 2019 that specializes in early-stage investments in the fields of neuroscience, mental health, and related technologies.
Iter Investments
A venture capital firm dedicated to supporting emerging companies within the psychedelic ecosystem focused on behavioral and mental health.
Palo Santo
A U.S.-based psychedelic healthcare investment fund focused on increasing the supply of clinically effective and accessible mental health and addiction treatment solutions.
What's next for Fluence?
With this recent infusion of capital, Fluence is poised to accelerate its operational growth and expand its curriculum offerings to meet the increasing global demand for specialized mental health training. The company's strategic roadmap focuses on deepening its integration with healthcare institutions and enhancing its digital learning environment. By leveraging its strong investor network, Fluence aims to scale its impact, ensuring that the next generation of clinicians is equipped to navigate the complexities of psychedelic medicine while maintaining the highest standards of patient safety and therapeutic efficacy.
See full Fluence company page
